Wells Fargo posts higher fourth-quarter profit, helped by higher interest rates and cost cutting

Wells Fargo posts higher fourth-quarter profit, helped by higher interest rates and cost cutting


Wells Fargo posts higher fourth-quarter profit, helped by higher interest rates and cost cutting

Wells Fargo shares fell Friday even after fourth-quarter profit rose from a year ago, as the bank warned that net interest income for 2024 could come in significantly lower year over year.

“As we look forward, our business performance remains sensitive to interest rates and the health of the U.S. economy, but we are confident that the actions we are taking will drive stronger returns over the cycle,” said CEO Charlie Scharf in the earnings release. “We are closely monitoring credit and while we see modest deterioration, it remains consistent with our expectations.”

Scharf said earnings in the latest period were helped by a strong economy and higher interest rates as well as cost-cutting efforts put in place by the bank. Still, Wells Fargo’s stock fell more than 3%.

Here’s what the bank reported versus what Wall Street was expecting based on a survey of analysts by LSEG, formerly known as Refinitiv:

  • Earnings per share: $1.29, adjusted vs. $1.17 expected.
  • Revenue: $20.48 billion vs. $20.30 billion expected.

In the quarter ending Dec. 31, 2023, Wells Fargo posted net income of $3.45 billion, or 86 cents per share, up slightly from $3.16 billion, or 75 cents a share, a year ago.

Earnings were lowered by a $1.9 billion charge from a Federal Deposit Insurance Corporation special assessment tied to the failures of Silicon Valley Bank and Signature Bank, and a $969 million charge from severance expenses. Wells Fargo also recorded a $621 million, or 17 cents per share, tax benefit. Excluding these items, the company earned $1.29 a share, which was better than analysts had predicted.

Total revenue came in at $20.48 billion for the period. That’s a 2% increase from the fourth quarter of 2022 when Wells Fargo posted $20.30 billion in revenue. The company also topped earnings expectations, posting adjusted earnings of $1.29 per share, versus an LSEG estimate of $1.17.

Wells Fargo said net interest income fell 5% from a year ago to $12.78 billion, and warned that the figure could come in 7% to 9% lower for the full year from $52.4 billion in 2023. The decline in net interest income was due to lower deposit and loan balances, but offset slightly by higher interest rates, the bank said.

Provisions for credit losses rose 34% to $1.28 billion from $957 million a year ago, as allowances for credit losses rose for credit card and commercial real estate loans. Wells Fargo said that was partially offset by lower allowances for auto loans.

Wells Fargo shares are virtually flat this year after rallying more than 19% in 2023. During the period, the 10-year Treasury yield topped the 5% threshold in October, before finishing the year below 3.9%.

Don’t miss these stories from CNBC PRO:



Source

The  million Trump Card faces legal challenges, limited market
Business

The $5 million Trump Card faces legal challenges, limited market

U.S. President Donald Trump holds “The Trump Card” as he speaks with journalists onboard Air Force One en route to Miami, Florida, U.S., April 3, 2025. Kent Nishimura | Reuters A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to […]

Read More
Nike will report earnings after the bell. Here’s what Wall Street expects
Business

Nike will report earnings after the bell. Here’s what Wall Street expects

A shopper walks past a Nike store, as global markets brace for a hit to trade and growth caused by U.S. President Donald Trump’s decision to impose import tariffs on dozens of countries, in the King of Prussia Mall in King of Prussia, Pennsylvania, U.S., April 3, 2025.  Rachel Wisniewski | Reuters Nike is expected […]

Read More
RFK Jr.’s CDC vaccine panel backs Merck RSV shot for infants
Business

RFK Jr.’s CDC vaccine panel backs Merck RSV shot for infants

Nikos Pekiaridis | Nurphoto | Getty Images Robert F. Kennedy Jr.’s revamped government panel of outside vaccine advisors on Thursday recommended the use of Merck‘s shot to protect infants from respiratory syncytial virus, a temporary reprieve for public health officials and companies concerned about the Health and Human Services secretary’s immunization policy. The group, called […]

Read More